Skip to main content
SpringerLink
Log in

Combined Therapies of RFA

  • Chapter
  • First Online:
Radiofrequency Ablation for Small Hepatocellular Carcinoma

  • 689 Accesses

Abstract

RFA has been widely utilized in the treatment of small HCC (≤3 cm) with encouraging results. However, the limited volume of coagulative necrosis obtained with RFA systems and the occasionally irregular burn shape caused by the heat sink activity of the large vessels in the proximity of the ablated area have prevented the widespread use of RFA in the treatment of hepatic tumors. To obtain a large coagulation area, various techniques including transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), balloon occlusion of the hepatic artery and saline infusion during RFA, and so on have been used.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen MS, Li JQ, Zheng YJ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  3. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119–26.

    Article  CAS  PubMed  Google Scholar 

  4. Seki T, Tamai T, Nakagawa T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. 2000;89:1245–51.

    Article  CAS  PubMed  Google Scholar 

  5. Shibata T, Isoda H, Hirokawa Y, et al. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905–13.

    Article  PubMed  Google Scholar 

  6. Morimoto M, Numata K, Kondou M, et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer. 2010;116:5452–60.

    Article  PubMed  Google Scholar 

  7. Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32.

    Article  PubMed  Google Scholar 

  8. Yang W, Chen MH, Wang MQ, et al. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res. 2009;39:231–40.

    Article  CAS  PubMed  Google Scholar 

  9. Shen SQ, Xiang JJ, Xiong CL, et al. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology. 2005;52:1403–7.

    PubMed  Google Scholar 

  10. Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci. 2012;57:3026–31.

    Article  CAS  PubMed  Google Scholar 

  11. Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int. 2010;30:741–9.

    Article  PubMed  Google Scholar 

  12. Schwartz M, Weintraub J. Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nat Clin Pract Oncol. 2008;5:630–1.

    Article  PubMed  Google Scholar 

  13. Peng ZW, Zhang YJ, Chen MS, et al. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and radiofrequency ablation versus radiofrequency ablation alone: a prospective randomized trial. Radiology. 2012;262:689–700.

    Article  PubMed  Google Scholar 

  14. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244:599–607.

    Article  PubMed  Google Scholar 

  15. Cha DI, Lee MW, Rhim H, et al. Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations. Korean J Radiol. 2013;14:240–7.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol. 2008;190:W187–95.

    Article  PubMed  Google Scholar 

  17. Fisher RA, Maluf D, Cotterell AH, et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant. 2004;18:502–12.

    Article  CAS  PubMed  Google Scholar 

  18. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Latteri F, Sandonato L, Di Marco V, et al. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40:684–9.

    Article  CAS  PubMed  Google Scholar 

  20. Choi D, Lim HK, Joh JW, et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol. 2007;14:3510–8.

    Article  PubMed  Google Scholar 

  21. Taniai N, Yoshida H, Mamada Y, et al. Is intraoperative adjuvant therapy effective for satellite lesions in patients undergoing reduction surgery for advanced hepatocellular carcinoma? Hepatogastroenterology. 2006;53(68):258–61.

    PubMed  Google Scholar 

  22. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319–29.

    Article  PubMed  Google Scholar 

  23. Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol. 2008;15:3484–93.

    Article  PubMed  Google Scholar 

  24. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

    Article  CAS  PubMed  Google Scholar 

  25. Xu M, Xie XH, Xie XY, et al. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo. Acta Radiol. 2013;54:199–204.

    Article  PubMed  Google Scholar 

  26. Mertens JC, Martin IV, Schmitt J, et al. Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals. Eur J Radiol. 2012;81:1601–6.

    Article  PubMed  Google Scholar 

  27. Li Y, Zheng YB, Zhao W, et al. Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma. Med Oncol. 2013;30:730.

    Article  PubMed  Google Scholar 

  28. Goldberg SN, Kamel JR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol. 2002;179:93–101.

    Article  Google Scholar 

  29. Wang JH, Tung HD, Chen TY, et al. Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin. Hepatol Int. 2010;5:567–74.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hong CW, Libutti SK, Wood BJ. Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma. Curr Oncol. 2013;20:e274–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ma HQ, Zhang YJ, Wang QJ, et al. Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biol Ther. 2010;9:903–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Zhenwei Peng MD, PhD

  2. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China

    Minshan Chen MD, PhD

Authors
  1. Zhenwei Peng MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Minshan Chen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minshan Chen MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Minshan Chen

  2. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Yaojun Zhang

  3. Prince of Wales Hospital, Chinese University of Hong Kong Prince of Wales Hospital, Hong Kong, China

    W.Y. Lau

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Peng, Z., Chen, M. (2016). Combined Therapies of RFA. In: Chen, M., Zhang, Y., Lau, W. (eds) Radiofrequency Ablation for Small Hepatocellular Carcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7258-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7258-7_8

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7257-0

  • Online ISBN: 978-94-017-7258-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation